drugset / Trial / NCT02714400

The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea

NCT02714400

Phase 4 Completed 20 enrolled University of California, San Diego
RandomizedCrossoverTriple-blindTreatment

Summary

The investigators hypothesis is that obstructive sleep apnea (OSA) patients with a low arousal threshold may wake up too early during a respiratory event, before upper airway muscles can be activated to achieve stable ventilation. Thus, strategies to manipulate the respiratory arousal threshold could potentially improve the quality of sleep and sleep disordered breathing. Agents that raise arousal threshold are therefore likely to benefit some patients with OSA. The overall goal of this project is to determine the importance of the arousal threshold in OSA, determine which patients might benefit from a raised arousal threshold, and test this hypothesis by using pharmacological manipulation of the arousal threshold to achieve this goal.

Timeline

Start
2016-03
Primary completion
2016-07
Completion
2016-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Venlafaxine Small molecule 50 mg